RU2016141287A3 - - Google Patents

Download PDF

Info

Publication number
RU2016141287A3
RU2016141287A3 RU2016141287A RU2016141287A RU2016141287A3 RU 2016141287 A3 RU2016141287 A3 RU 2016141287A3 RU 2016141287 A RU2016141287 A RU 2016141287A RU 2016141287 A RU2016141287 A RU 2016141287A RU 2016141287 A3 RU2016141287 A3 RU 2016141287A3
Authority
RU
Russia
Application number
RU2016141287A
Other languages
Russian (ru)
Other versions
RU2687150C2 (ru
RU2016141287A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016141287A publication Critical patent/RU2016141287A/ru
Publication of RU2016141287A3 publication Critical patent/RU2016141287A3/ru
Application granted granted Critical
Publication of RU2687150C2 publication Critical patent/RU2687150C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2016141287A 2014-03-21 2015-03-25 Не встречающийся в природе вирус репродуктивно-респираторного синдрома свиней (bppcc) и способы применения RU2687150C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461968465P 2014-03-21 2014-03-21
US61/968,465 2014-03-21
PCT/IB2015/052214 WO2015140774A1 (en) 2014-03-21 2015-03-25 A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using

Publications (3)

Publication Number Publication Date
RU2016141287A RU2016141287A (ru) 2018-04-26
RU2016141287A3 true RU2016141287A3 (ja) 2018-06-07
RU2687150C2 RU2687150C2 (ru) 2019-05-07

Family

ID=54143830

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016141287A RU2687150C2 (ru) 2014-03-21 2015-03-25 Не встречающийся в природе вирус репродуктивно-респираторного синдрома свиней (bppcc) и способы применения

Country Status (11)

Country Link
US (3) US10072046B2 (ja)
EP (1) EP3119429A4 (ja)
JP (1) JP6538071B2 (ja)
KR (1) KR20170002393A (ja)
CN (1) CN107635579A (ja)
CA (1) CA2943478A1 (ja)
HK (1) HK1247128A1 (ja)
MX (1) MX2016012276A (ja)
PH (2) PH12016501854B1 (ja)
RU (1) RU2687150C2 (ja)
WO (1) WO2015140774A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10072046B2 (en) 2014-03-21 2018-09-11 Nutech Ventures Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using
TWI704225B (zh) * 2016-02-18 2020-09-11 美商益農美國公司 豬繁殖與呼吸綜合症疫苗病毒
US20240189418A1 (en) * 2021-03-31 2024-06-13 The Industry & Academic Cooperation In Chungnam National University (Iac) Virus vaccine based on virus surface engineering providing increased immunity

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US6380376B1 (en) * 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
PT980387E (pt) 1997-05-06 2007-07-31 Boehringer Ingelheim Vetmed Sítios antigénicos de prrsv que identificam sequências peptídicas do vírus prrsv para utilização em vacinas ou em ensaios de diagnóstico
CA2370372C (en) * 1999-04-22 2009-02-24 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
US20020012670A1 (en) 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
CZ20022554A3 (cs) * 2000-01-26 2002-10-16 Boehringer Ingelheim Vetmedica Gmbh ®ivý oslabený virus PRRS, nukleotidová sekvence a farmaceutický prostředek
EP1929047B1 (en) 2005-08-30 2010-03-17 Board of Regents of the University of Nebraska Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity
EP1962900A2 (en) * 2005-11-29 2008-09-03 Iowa State University Research Foundation, Inc. Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
UA108902C2 (uk) 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
WO2013017568A1 (en) * 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
US9187731B2 (en) * 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
EP2620446A1 (en) * 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
US10072046B2 (en) * 2014-03-21 2018-09-11 Nutech Ventures Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using

Also Published As

Publication number Publication date
US10072046B2 (en) 2018-09-11
PH12016501854A1 (en) 2017-01-09
EP3119429A1 (en) 2017-01-25
US20200331970A1 (en) 2020-10-22
PH12016501854B1 (en) 2017-01-09
EP3119429A4 (en) 2018-04-04
US11136355B2 (en) 2021-10-05
HK1247128A1 (zh) 2018-09-21
CN107635579A (zh) 2018-01-26
WO2015140774A1 (en) 2015-09-24
US20190048042A1 (en) 2019-02-14
RU2687150C2 (ru) 2019-05-07
PH12020550204A1 (en) 2021-01-11
US20170198016A1 (en) 2017-07-13
RU2016141287A (ru) 2018-04-26
KR20170002393A (ko) 2017-01-06
JP6538071B2 (ja) 2019-07-03
US10738088B2 (en) 2020-08-11
JP2017510276A (ja) 2017-04-13
CA2943478A1 (en) 2015-09-24
MX2016012276A (es) 2017-06-12

Similar Documents

Publication Publication Date Title
RU2016134234A3 (ja)
BR112016025867A2 (ja)
BR112016019835A2 (ja)
BR112016022014A2 (ja)
BR112016016088A2 (ja)
BR112016013761A2 (ja)
BR112016025597A2 (ja)
BR112016017455A2 (ja)
BR112016018514A2 (ja)
BR112016026714A2 (ja)
BR112016025804A2 (ja)
BR112016015542A2 (ja)
BR112016027656A2 (ja)
BR112016026000A2 (ja)
BR112016025892A2 (ja)
BR112016022959A2 (ja)
BR112016026639A2 (ja)
BR112016030921A2 (ja)
BR112016030861A2 (ja)
BR112016030498A2 (ja)
BR112016027829A2 (ja)
BR112016026440A2 (ja)
RU2016141287A3 (ja)
BR112016020986A2 (ja)
BR112016026917A2 (ja)

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20210326